Talaris Therapeutics Funding: $365M Raised, Other Equity
Talaris Therapeutics is based in Boston, MA. It has raised $365M in total funding. Latest round: Other Equity.
Talaris Therapeutics funding overview
Talaris Therapeutics is based in Boston, MA. Talaris Therapeutics has raised $365M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an Other Equity announced in May 2021. The round record for Talaris Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Scott Requadt, Qiming Venture Partners USA, Sandip Agarwala, Surveyor Capital, Viking Global Investors, Aisling Capital and 8 others. 14 distinct backers are named across the disclosed rounds.
Talaris Therapeutics at a glance
Total raised
$365M
Latest round
Other Equity
Latest round date
May 2021
Headquarters
Boston, MA
Notable investors
Scott Requadt, Qiming Venture Partners USA, Sandip Agarwala, Surveyor Capital, Viking Global Investors, Aisling Capital, BlackRock, Blackstone
Frequently asked about Talaris Therapeutics funding
How much has Talaris Therapeutics raised?
Talaris Therapeutics has raised $365M in total disclosed funding across the rounds on record.
Who has invested in Talaris Therapeutics?
Scott Requadt, Qiming Venture Partners USA, Sandip Agarwala, Surveyor Capital, Viking Global Investors, Aisling Capital are named among the investors backing Talaris Therapeutics.
What was the latest Talaris Therapeutics funding round?
The most recent disclosed round is an Other Equity, announced in May 2021.
Where is Talaris Therapeutics based?
Talaris Therapeutics is based in Boston, MA.
When did Talaris Therapeutics last raise?
The last disclosed Talaris Therapeutics round closed in May 2021 at Other Equity.
We update the Talaris Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Boston and their backers are listed below.
